Tegal Corporation Company Profile
Since its founding in 1972, Tegal Corporation has been dedicated to the development and application of emerging technologies. Often on the forefront of major inventions, Tegal’s process and capital equipment know-how enabled the development and manufacturing of leading-edge devices – from early microprocessors to advanced memory and LEDs, as well as to newest filtering and sensing devices that are present in the most advanced smart phones. Tegal draws upon its historic market and technology leadership in semiconductors and MEMS devices to engage in the promotion of other emerging technologies, including PV-based solar power generation and medical devices. Tegal is actively evaluating opportunities for partnerships with diversified technology-based companies in order to exploit our shared experience and to enhance our value as a public company. Tegal is headquartered in Petaluma, California. Please visit us on the web at www.tegal.com.
News Articles
Tegal Shifts to Health Tech with CollabRx Acquisition
North Bay Business Journal | Former semiconductor production equipment maker Tegal Corp. is transforming itself into a healthcare technology company with the deal to acquire gene-based cancer care i...
James Karis Teams With Tegal’s Thomas Mika as Co-CEO of Tegal Corporation
Tegal Corporation (NASDAQ:TGAL) today announced that it expects to appoint James Karis as Co-CEO of Tegal Corporation. The appointment will be effective upon completion of Tegalâ€...
Tegal Corporation (NASDAQ: TGAL) today announced the closing of a transaction to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of inter...
Tegal Receives Shareholder Approval to Change Corporate Name to CollabRx, Inc.
Tegal Corporation (NASDAQ: TGAL) today announced shareholder approval of an amendment to its Certificate of Incorporation changing its corporate name to CollabRx, Inc. Tegal obtai...
Tegal Corporation to Acquire CollabRx, Inc.
Tegal Corporation (NASDAQ:TGAL) today announced that it has signed a definitive agreement to acquire CollabRx, Inc., a privately held technology company in the rapidly growing mar...
Tegal Corporation Reports Q1 Fiscal Year 2013 Financial Results
Tegal Corporation (NASDAQ: TGAL) today announced financial results for the First Quarter Fiscal Year 2013, which ended June 30, 2012. Fiscal 2013 First Quarter Financial...
Tegal Corporation (NASDAQ: TGAL) today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietar...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Since its founding in 1972, Tegal Corporation has been dedicated to the development and application of emerging technologies. Often on the forefront of major inventions, Tegalâ€...
More Information about "Tegal Corporation" on BioPortfolio
We have published hundreds of Tegal Corporation news stories on BioPortfolio along with dozens of Tegal Corporation Clinical Trials and PubMed Articles about Tegal Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tegal Corporation Companies in our database. You can also find out about relevant Tegal Corporation Drugs and Medications on this site too.
